Built for one job, done properly.
Lucido is a day-of-treatment monitor for Spravato® (esketamine) clinics. It runs the FDA-required two-hour monitoring window after every dose, captures the vitals and observations REMS asks for, and produces the SPRAVATO® REMS Patient Monitoring Form at discharge — so a clinic isn't running one of the strictest monitoring-and-filing regimes in outpatient medicine on a clipboard and a spreadsheet.
Why we built it
Spravato® REMS requires vitals before the dose, around the 40-minute mark, and again before discharge, observations logged through the two-hour window, and a signed monitoring form filed within seven days of every session. The tools most clinics reach for — a paper checklist, a spreadsheet, a few EHR fields — were never built around a fixed monitoring window or a hard filing deadline.
Lucido runs that day in one place: a live view of every room, capture at the bedside, an optional calm companion on the patient's own phone, and a finished REMS form waiting at discharge. The enforced two-hour window, locked session records, and the append-only audit log have been in Lucido since the first version.
That's the principle we keep coming back to: Lucido is the cockpit, not the filing cabinet. It runs the session in real time, captures every field the REMS form needs as it happens, and files the finished form to the REMS program with one click, with delivery confirmed and the receipt kept. The session record auto-deletes after the clinic's retention window, so no permanent PHI footprint accumulates and the clinic's own export stays the system of record.
Security and compliance
Lucido runs entirely on HIPAA-eligible Amazon Web Services under a signed Business Associate Agreement, with PHI encrypted in transit and at rest, enforced two-factor sign-in, and a seven-year append-only audit trail. Behind the product sits a written HIPAA program — a security risk analysis, incident-response and breach-notification procedures, and workforce policies — kept current as the product changes.
Esketamine records are mental-health records. Where a state law such as the Illinois Mental Health and Developmental Disabilities Confidentiality Act protects them more strictly than HIPAA, the architecture is built to honor it.
Who's behind it
Lucido is built and operated by Lee Wilkins, founder of TASHABAR LLC (doing business as Lucido).
Lee is an Associate Chartered Accountant (ACA, ICAEW) and a Certified Fraud Examiner (CFE) with over a decade in compliance, forensic investigations, and integrity services — a career spanning a Big Four consultancy, a global IT consultancy, and a boutique compliance and investigations firm. That work has run from anti-bribery and FCPA audits across high-risk jurisdictions to healthcare-compliance reviews for pharmaceutical clients. Lucido is built the way audit evidence has to be: captured at the time and unchanged afterward.
It's a deliberately small company: support email goes to the founder, and the answer usually comes the same day.
The company
Lucido is a product of TASHABAR LLC, doing business as Lucido, organized in Illinois. Lucido is independent: it is not affiliated with, sponsored by, or endorsed by Janssen Pharmaceuticals. Pricing is $180 a month per clinic location, month-to-month, with no per-session or per-patient fees — details on the pricing page. Questions, demos, or a security review: support@lucido-go.com.
Try it at your own clinic.
Sign up and set your clinic up yourself, no sales call needed, or request demo access and a 20-minute live walkthrough with the founder.